Department of Small Animal Clinical Sciences, University of Florida, Gainesville, Florida, United States.
Institute for Wound Research, University of Florida, Gainesville, Florida, United States.
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5509-5521. doi: 10.1167/iovs.17-23085.
To evaluate the effect of topical suberanilohydroxamic acid (SAHA) and 5-methyl-1-phenyl-2[1H]-pyridone (pirfenidone) on the degree of corneal haze in the stromal wounded ex vivo canine cornea.
Twenty-four corneoscleral rims from normal dogs were uniformly wounded with an excimer laser and placed into culture medium with an air-liquid interface. The control group (n = 8) contained placebo-treated corneas. Treatment group 1 (n = 8) received SAHA topically every 6 hours. Treatment group 2 (n = 8) received pirfenidone topically every 6 hours. Each cornea was fluorescein stained and macrophotographed every 6 hours to assess epithelialization rate. All corneas were also macrophotographed weekly to assess optical clarity (haze). Images were analyzed for differences in pixel intensity between wounded (haze) and unwounded (nonhaze) regions, and haze surface area for each cornea was calculated.
The mean epithelialization time was 47.25 hours in the control group, 45.00 hours in the SAHA group, and 43.50 hours in the pirfenidone group, revealing no significant difference (P = 0.368). The median difference in pixel intensity between haze and nonhaze areas was 21.5 in the control group, 8.0 in the SAHA group, and 8.0 in the pirfenidone group, which is significant (P < 0.01). The median haze surface area was 12.96 mm2 in the control group, 5.70 mm2 in the SAHA group, and 5.92 mm2 in the pirfenidone group, which is significant (P < 0.01).
Stromal-wounded ex vivo canine corneas exhibited greater optical clarity when treated with SAHA and pirfenidone than when placebo treated at 21 days. There was no significant difference in epithelialization rate between groups. Corneal contour was correlated with geographic haze distribution.
评估局部应用苏贝替羟肟酸(SAHA)和 5-甲基-1-苯基-2[1H]-吡啶酮(吡非尼酮)对体外犬角膜基质创伤后角膜混浊程度的影响。
将 24 个正常犬的角巩膜缘均匀地用准分子激光创伤,并置于具有气液界面的培养基中。对照组(n=8)包含安慰剂处理的角膜。治疗组 1(n=8)每 6 小时局部应用 SAHA。治疗组 2(n=8)每 6 小时局部应用吡非尼酮。每只角膜每 6 小时用荧光素染色并拍摄大体照片以评估上皮化率。所有角膜每周拍摄大体照片以评估光学清晰度(混浊度)。分析图像以评估创伤(混浊)和未创伤(非混浊)区域之间的像素强度差异,并计算每个角膜的混浊表面积。
对照组的平均上皮化时间为 47.25 小时,SAHA 组为 45.00 小时,吡非尼酮组为 43.50 小时,无显著差异(P=0.368)。对照组混浊区与非混浊区之间的像素强度差异中位数为 21.5,SAHA 组为 8.0,吡非尼酮组为 8.0,差异显著(P<0.01)。对照组混浊表面积中位数为 12.96mm2,SAHA 组为 5.70mm2,吡非尼酮组为 5.92mm2,差异显著(P<0.01)。
与安慰剂处理相比,在第 21 天,用 SAHA 和吡非尼酮处理的体外犬角膜基质创伤后角膜表现出更高的光学清晰度。各组间上皮化率无显著差异。角膜轮廓与地理混浊分布相关。